HKSE - Delayed Quote HKD
IMMUNEONCO-B (1541.HK)
6.440
+0.050
+(0.78%)
At close: May 9 at 4:08:05 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-128,035
-128,035
-367,554
-238,710
-190,541
Investing Cash Flow
37,946
37,946
-294,845
49
-108,722
Financing Cash Flow
258,925
258,925
331,035
179,380
793,033
End Cash Position
477,601
477,601
306,983
635,212
668,326
Capital Expenditure
-10,404
-10,404
-2,691
-23,224
-125,253
Issuance of Capital Stock
215,941
215,941
307,793
189,570
800,975
Issuance of Debt
175,780
175,780
79,960
0
10
Repayment of Debt
-120,370
-120,370
-19,980
0
-10
Free Cash Flow
-138,439
-138,439
-370,245
-261,934
-315,794
12/31/2021 - 9/5/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2157.HK Lepu Biopharma Co., Ltd.
4.490
-3.44%
6955.HK Shandong Boan Biotechnology Co., Ltd.
9.370
-1.78%
1877.HK JUNSHI BIO
14.800
+0.14%
1167.HK JACOBIO-B
3.960
+8.79%
9966.HK Alphamab Oncology
7.340
+2.37%
9995.HK RemeGen Co., Ltd.
37.450
-3.48%
1801.HK INNOVENT BIO
52.400
+1.35%
1672.HK ASCLETIS-B
6.610
-0.90%
9688.HK Zai Lab Limited
23.600
+5.59%
UPB Upstream Bio, Inc.
8.82
-0.23%